Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city
暂无分享,去创建一个
A. Orcau | J. Caylà | J. Franch-Nadal | J. Julve | J. Real | M. Mata-Cases | B. Vlacho | J. Millet | Violeta Antonio-Arques | Elena Navas Mendez | Rai Puig Treserra | A. Moreno-martínez | D. Mauricio | J. L. Del Val García
[1] D. van Soolingen,et al. The impact of diabetes mellitus on pulmonary TB. , 2022, Public Health Action.
[2] A. Orcau,et al. Subjects With Diabetes Mellitus Are at Increased Risk for Developing Tuberculosis: A Cohort Study in an Inner-City District of Barcelona (Spain) , 2022, Frontiers in Public Health.
[3] D. Yanifitri,et al. High glycosylated hemoglobin level as a risk factor of latent tuberculosis infection in patients with uncomplicated type 2 diabetes mellitus , 2022, Universa Medicina.
[4] P. Preux,et al. DECREASE OF GLYCATED HEMOGLOBIN BASED ON EVALUATION OF DIABETES INTERVENTION PROGRAMS IN LOW-AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW , 2022, Diabetes Epidemiology and Management.
[5] Ranran Song,et al. The association of glycemic level and prevalence of tuberculosis: a meta-analysis , 2021, BMC Endocrine Disorders.
[6] E. Schouten,et al. Risk of having pulmonary tuberculosis in type 2 diabetes: A hospital-based matched case-control study. , 2021, Asia Pacific Journal of Clinical Nutrition.
[7] J. A. Caylà,et al. Diabetes y tuberculosis: una sindemia complicada por la COVID-19 , 2021, Medicina Clínica.
[8] Tewodros Shibabaw,et al. Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis , 2019, Journal of immunology research.
[9] J. Critchley,et al. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[10] D. Cook,et al. Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study , 2018, Diabetes Care.
[11] J. Valcour,et al. Diabetes and the occurrence of infection in primary care: a matched cohort study , 2018, BMC Infectious Diseases.
[12] M. Castellanos,et al. Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Shi-chuan Chang,et al. The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients , 2017, PloS one.
[14] A. Elliot,et al. Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study , 2017, Diabetic medicine : a journal of the British Diabetic Association.
[15] V. Mahishale,et al. Effect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus , 2017, Iranian journal of medical sciences.
[16] D. Mauricio,et al. Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain. , 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.
[17] Hsien-Ho Lin,et al. Glycemic Control and the Risk of Tuberculosis: A Cohort Study , 2016, PLoS medicine.
[18] P. Kearney,et al. Risk Factors for Macro- and Microvascular Complications among Older Adults with Diagnosed Type 2 Diabetes: Findings from The Irish Longitudinal Study on Ageing , 2016, Journal of diabetes research.
[19] R. Kempker,et al. Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis , 2016, Open forum infectious diseases.
[20] M. Casals,et al. Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[21] L. Smeeth,et al. Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink , 2015, BMC Medicine.
[22] Jen-Jyh Lee,et al. The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis , 2015, PloS one.
[23] Isaac Subirana,et al. Building Bivariate Tables: The compareGroups Package for R , 2014 .
[24] Jen-Jyh Lee,et al. Glycemic Control and Radiographic Manifestations of Tuberculosis in Diabetic Patients , 2014, PloS one.
[25] W. Haas,et al. Epidemiology of tuberculosis in big cities of the European Union and European Economic Area countries. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[26] Hsing-Yi Chang,et al. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] H. Sørensen,et al. Diabetes, Glycemic Control, and Risk of Tuberculosis , 2011, Diabetes Care.
[28] L. Anibarro,et al. [Consensus document on the diagnosis, treatment and prevention of tuberculosis]. , 2010, Archivos de bronconeumologia.
[29] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[30] M. Murray,et al. Correction: Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies , 2008, PLoS Medicine.
[31] G. Leung,et al. Diabetic control and risk of tuberculosis: a cohort study. , 2008, American journal of epidemiology.
[32] M. F. Domínguez-Berjón,et al. Construcción de un índice de privación a partir de datos censales en grandes ciudades españolas (Proyecto MEDEA) , 2008 .
[33] Peter Jüni,et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. , 2006, American heart journal.
[34] F. Schellevis,et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Hux,et al. Quantifying the risk of infectious diseases for people with diabetes. , 2003, Diabetes care.
[36] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[37] A. Dreher. Modeling Survival Data Extending The Cox Model , 2016 .
[38] K. Shadan,et al. Available online: , 2012 .